The store will not work correctly when cookies are disabled.
7-((6-isopropoxypyridin-3-ylsulfonyl)methyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepine
ID: ALA1078461
PubChem CID: 46882794
Max Phase: Preclinical
Molecular Formula: C19H24N2O3S
Molecular Weight: 360.48
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)Oc1ccc(S(=O)(=O)Cc2ccc3c(c2)CCNCC3)cn1
Standard InChI: InChI=1S/C19H24N2O3S/c1-14(2)24-19-6-5-18(12-21-19)25(22,23)13-15-3-4-16-7-9-20-10-8-17(16)11-15/h3-6,11-12,14,20H,7-10,13H2,1-2H3
Standard InChI Key: BMTKUMNAVZOJQX-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
6.1360 -5.3848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1347 -6.2087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8530 -6.6221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8510 -4.9716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3639 -5.8009 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.0084 -5.0540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2055 -4.8705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0063 -6.5409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2023 -6.7238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5618 -6.2064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5608 -5.3809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4195 -6.6216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7043 -6.2087 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.9890 -6.6215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2840 -5.4904 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1098 -5.4904 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2756 -6.2077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5609 -6.6200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5603 -7.4467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2806 -7.8594 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9924 -7.4449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8457 -7.8605 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.1300 -7.4485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4152 -7.8623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1289 -6.6226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 1 1 0
5 6 1 0
2 12 1 0
6 7 1 0
12 13 1 0
5 8 1 0
13 14 1 0
9 10 1 0
13 15 2 0
10 11 1 0
13 16 2 0
11 7 1 0
14 17 2 0
8 9 1 0
17 18 1 0
2 3 1 0
18 19 2 0
19 20 1 0
3 10 2 0
20 21 2 0
21 14 1 0
19 22 1 0
22 23 1 0
1 2 2 0
23 24 1 0
11 4 2 0
23 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 360.48 | Molecular Weight (Monoisotopic): 360.1508 | AlogP: 2.53 | #Rotatable Bonds: 5 |
Polar Surface Area: 68.29 | Molecular Species: BASE | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.86 | CX LogP: 2.57 | CX LogD: 0.18 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.89 | Np Likeness Score: -1.36 |
References
1. Bailey JM, Scott JS, Basilla JB, Bolton VJ, Boyfield I, Evans DG, Fleury E, Heightman TD, Jarvie EM, Lawless K, Matthews KL, McKay F, Mok H, Muir A, Orlek BS, Sanger GJ, Stemp G, Stevens AJ, Thompson M, Ward J, Vaidya K, Westaway SM.. (2009) The discovery and optimisation of benzazepine sulfonamide and sulfones as potent agonists of the motilin receptor., 19 (22): [PMID:19804969] [10.1016/j.bmcl.2009.09.027] |